Skip to main content
Advicenne logo

Advicenne — Investor Relations & Filings

Ticker · ALDVI ISIN · FR0013296746 LEI · 969500YT5VMEYAYODW34 PA Manufacturing
Open in API
Filings indexed 263 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country FR France
Listing PA ALDVI

About Advicenne

https://advicenne.com

Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing that the French social security system will reimburse Likozam®, thereby reducing the company’s debt by nearly €6 million. It contains no financial statements, earnings figures, board changes, share issues, or regulatory voting results, and is not a call transcript or investor presentation. It is a standalone announcement of a commercial and financial impact event, fitting the fallback category for general regulatory/market announcements. Therefore it should be classified as a Regulatory Filing (RNS).
2026-06-01 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 68% confidence The document is a corporate press release announcing that Advicenne’s drug Likozam® has received reimbursement status in France, the official price published in the Journal Officiel, and the resultant reduction in debt. It contains no financial statements or results, no fundraising or capital transaction, no management discussion of quarterly or annual results, nor any report attachment. It is a standalone announcement of a regulatory decision by French authorities, falling into the catch-all “general regulatory announcements” category. Therefore, it should be classified as Regulatory Filings (RNS).
2026-06-01 French
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 90% confidence The document is a press release detailing changes in the board of directors and senior management following the Annual General Meeting (naming new appointments, renewing mandates, and appointing committee chairs). This clearly fits the Board/Management Information category.
2026-05-21 French
Inside Information / Other news releases
Board/Management Information Classification · 85% confidence The document is a press release announcing updates to Advicenne’s governance following its AGM, specifically the appointment and composition of board members and committee chairs. It is not the full AGM materials, voting tallies, or an annual report, but rather an announcement of board changes. This matches the Board/Management Information category.
2026-05-21 English
Inside Information / Other news releases
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the opening of safeguard proceedings to restructure the company's financial liabilities and finalize the extension of its cash runway. It details the legal framework, debt amounts, ongoing negotiations, and the appointment of judicial administrators. There are no financial statements, detailed financial performance data, or comprehensive management analysis typical of annual or interim reports. The document is primarily an update on the company's financial restructuring and legal status, which fits the category of a Capital/Financing Update. It is not a full financial report, earnings release, or regulatory filing of another type. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-05-05 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release announcing the opening of a 'procédure de sauvegarde' (a French legal safeguard procedure) to restructure the company's financial liabilities and extend its cash runway. It details the company's current debt situation, ongoing negotiations with creditors, and plans for financing. The document also mentions a scheduled webcast for shareholders and provides background on the company and the safeguard procedure. There are no financial statements, detailed financial performance data, or comprehensive management analysis included. The document is primarily an announcement of a significant financial restructuring event and related procedural information. It does not fit the definitions of Annual Report, Interim Report, Earnings Release, or other detailed financial filings. It is a regulatory announcement about a legal and financial restructuring process. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-05-05 French

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.